| Not Yet Recruiting | Study of Treosulfan-Based Conditioning for HSCT in Nijmegen Breakage Syndrome HSCT, Nijmegen Breakage Syndrome, Treosulfan Based Conditioning | Phase 2 | 2025-12-30 |
| Recruiting | Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapse Neuroblastoma (NB), Ganglioneuroblastoma | Phase 3 | 2025-11-19 |
| Recruiting | Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graf Acute Myeloid Leukemia, Relapsed, Acute Lymphoblastic Leukemia, High Risk, Acute Myeloid Leukemia, High Risk | Phase 2 / Phase 3 | 2025-09-03 |
| Recruiting | The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in Russia AML (Acute Myelogenous Leukemia), Down Syndrome (DS) | Phase 3 | 2025-07-24 |
| Recruiting | Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Acute Myeloid Leukemia, Acute Lymphoblastic T-cell Leukemia, Mixed Phenotype Acute Leukemia | Phase 2 | 2025-05-09 |
| Active Not Recruiting | Emapalumab Efficacy in Children With Primary Hemophagocytic Lymphohistiocytosis Primary Hemophagocytic Lymphohistiocytosis | — | 2024-08-01 |
| Recruiting | Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Child Biphenotypic Acute Leukemia, Acute Lymphoblastic Leukemia, Myeloblastic Leukemia | Phase 2 / Phase 3 | 2024-07-10 |
| Completed | Successful Treatment of Netherton Syndrome With Combination of Secukinumab and Dupilumab Neterton Syndrome | — | 2023-12-19 |
| Active Not Recruiting | Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Child Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia | Phase 2 / Phase 3 | 2023-12-01 |
| Recruiting | Low Dose Treosulfan Based Conditioning Regimen and PTCy in HSCT for Nijmegen Breakage Syndrome Nijmegen Breakage Syndrome | Phase 2 | 2023-11-22 |
| Recruiting | PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patient Inborn Errors of Immunity | Phase 2 | 2023-11-21 |
| Recruiting | Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification Neuroblastoma, Ganglioneuroma, Ganglioneuroblastoma | — | 2023-10-19 |
| Recruiting | Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma Neuroblastoma, Ganglioneuroblastoma | Phase 3 | 2023-09-01 |
| Unknown | Evaluation of Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety and Efficacy in the Treatment of Primary Immunodeficiency Diseases (PID) | — | 2022-09-01 |
| Active Not Recruiting | Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibito Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia | Phase 3 | 2022-08-23 |
| Recruiting | Efficacy and Safety of Sirolimus in Children and Adolescents With Juvenile Nasopharyngeal Angiofibroma (JNA) Juvenile Nasopharyngeal Angiofibroma | Phase 3 | 2022-05-30 |
| Recruiting | B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021 Non-hodgkin Lymphoma,B Cell, Burkitt Lymphoma, Primary Mediastinal Lymphoma | Phase 4 | 2022-05-25 |
| Unknown | Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and Adolesce Chemotherapy-induced Nausea and Vomiting | Phase 3 | 2022-04-01 |
| Recruiting | Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 D Acute Lymphoblastic Leukemia, Pediatric, ALL, Infants | Phase 3 | 2021-09-23 |
| Unknown | Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, in Relapse | Phase 1 / Phase 2 | 2021-09-16 |
| Not Yet Recruiting | Total Lymphoid Irradiation Pre-HSCT in Severe Congenital Neutropenia Severe Congenital Neutropenia, GATA2 Deficiency | Phase 2 | 2021-04-14 |
| Completed | Videoocular Assessment of Eye Movement Activity in an Ataxia Telangiectasia Ataxia Telangiectasia, Dysmetria | — | 2021-03-15 |
| Unknown | Quantitative MRI of Bone Marrow in Patients With Acute Lymphoblastic Leukemia Acute Leukemia | N/A | 2021-02-22 |
| Unknown | Evaluation of Brain Changes in ALL Patients on Therapy Acute Leukemia | N/A | 2021-02-16 |
| Unknown | Quantitative MRI of Bone Marrow Fat Fraction in Patients With Trepanobiopsy Aplastic Anemia, Aplastic Anemia Idiopathic | N/A | 2021-02-16 |
| Unknown | DWI in the Diagnosis of Histological Types of Nephroblastoma in Children Nephroblastoma (Wilms Tumour) | N/A | 2020-12-21 |
| Unknown | Fecal Microbiome Transplantation (FMT) in Pediatric Patients Colonized With Antibiotic-resistant Pathogens Bef Antibiotic Resistant Strain | Phase 2 | 2020-12-15 |
| Unknown | Rituximab and Abatacept Effectiveness in Differential Treatment of Interstitial Lymphocytic Lung Disease in Ch Interstitial Lymphocytic Lung Disease | — | 2020-09-07 |
| Active Not Recruiting | Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL B-ALL | Phase 1 / Phase 2 | 2020-07-27 |
| Unknown | Low Dose Treosulfan Based Conditioning Regimen in HSCT for Nijmegen Breakage Syndrome Nijmegen Breakage Syndrome | Phase 2 | 2020-05-22 |
| Unknown | Covid-19 Associated Coagulopathy Predicted by Thrombodynamic Markers (CoViTro-I) Coronavirus Disease 2019 | — | 2020-04-01 |
| Unknown | Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2019 Pilot Childhood Acute Lymphoblastic Leukemia | N/A | 2020-02-01 |
| Unknown | MRI T2* Mapping of Myocardium, Liver, Pancreas and Pituitary Gland Iron Overload | N/A | 2020-01-21 |
| Unknown | Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wi Wiskott-Aldrich Syndrome | Phase 2 | 2019-11-05 |
| Unknown | Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Ac Refractory Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia | Phase 3 | 2019-10-15 |
| Unknown | Modification of the Human Colon and Oral Microbiome by Allogenic HSCT Human Microbiome, HSCT | — | 2019-05-14 |
| Unknown | Brentuximab Vedotin as Alternative to the Autologous Stem Cell Transplantation in Relapsed and Refractory Clas Hodgkin's Lymphoma | Phase 2 | 2019-05-14 |
| Unknown | Plerixafor/G-CSF as Additional Agents for Conditioning Before HSCT in CGD Patients Chronic Granulomatous Disease | Phase 2 | 2019-04-13 |
| Unknown | A Prospective Multicenter Clinical Trial of MRD-based Treatment Strategy in Children and Young Adults With AML Acute Myeloid Leukemia, Childhood | Phase 3 | 2019-04-01 |
| Unknown | Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors Inflammatory Myofibroblastic Tumor | Phase 2 / Phase 3 | 2019-02-01 |
| Unknown | Metabolic Syndrome in Childhood Cancer Survivors Metabolic Syndrome | — | 2018-11-20 |
| Unknown | the Efficacy and Safety of Sugammadex in Children 0-2 Years Old Anesthesia, Pediatric Cancer, Pediatric Tumor | Phase 2 / Phase 3 | 2018-11-15 |
| Unknown | A Combination of Vemurafenib, Cytarabine and 2-chlorodeoxyadenosine in Children With LCH and BRAF V600E Mutati Langerhans Cell Histiocytosis | Phase 2 | 2018-06-26 |
| Unknown | CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL B-cell Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Pediatric | Phase 1 / Phase 2 | 2018-05-14 |
| Completed | Clinical Use of Pathogen Reduced Red Blood Cell Suspension Oncologic Disorders, Hematologic Diseases | Phase 3 | 2018-01-15 |
| Unknown | Creating a Decision Support System for the Corporate Management of Physical Therapy Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Brain Tumor, Physical Activity | — | 2017-11-01 |
| Completed | Cognitive and Motor Training in Pediatric Posterior Fossa Tumor Survivors Childhood Cancer, Cognitive Impairment, Motor Skills Disorders | N/A | 2017-11-01 |
| Unknown | Eltrombopag+hATG+CsA vs. hATG+CsA in Children With Severe AA Acquired Aplastic Anemia | Phase 3 | 2016-12-10 |
| Completed | CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT Leukemia, Lymphoma, Myelodysplastic Syndromes | Phase 2 / Phase 3 | 2016-10-01 |
| Unknown | A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS P Wiskott-Aldrich Syndrome, Hematopoietic Stem Cell Transplantation, Graft Failure | Phase 2 | 2016-06-01 |
| Unknown | Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2015 (ALL-MB 2015) Childhood Acute Lymphoblastic Leukemia | N/A | 2015-11-01 |
| Completed | IL-1 Receptor Inhibitor for Granulomatous Complications in Patients With Chronic Granulomatous Disease Chronic Granulomatous Disease | EARLY_Phase 1 | 2015-09-25 |
| Completed | Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantati Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Immune Deficiency Disease | Phase 1 / Phase 2 | 2014-08-01 |
| Completed | TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID Primary Immune Deficiency Disorder, Hematopoietic Stem Cell Transplantation | Phase 2 / Phase 3 | 2012-07-01 |
| Completed | Romiplostim Treatment for Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome. Wiskott-Aldrich Syndrome | — | 2012-04-01 |
| Unknown | Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008 Childhood Acute Lymphoblastic Leukemia | N/A | 2008-02-01 |